Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate

SHOBHA, Rani P.; AGRAWAL, Renu

Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate

Rani P. SHOBHA, (Department, of Food Microbiology, Central Food Technological Research Inst. Mysore-India)

Renu AGRAWAL (Department, of Food Microbiology, Central Food Technological Research Inst. Mysore-India)

Turkish Journal of Biology

1 0

Yıl: 2007 Cilt: 31 Sayı: 1 Sayfa Aralığı: 35 - 40 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate

Öz:

Abstract: Probiotics are a community of nutraceuticals. Their potential in functional foods serves to promote health or to prevent diseases. Ramping up of flavor profile is an ongoing trend in modern dairy, so designer products are at the forefront towards desired health, wellness and sensorial enjoyment of everyday life. In the present work, volatile compounds of a potentially beneficial culture, Leuconostoc paramesenteroides, isolated from Cheddar cheese were studied for 21 days. Culture grown in MRS broth was taken out periodically and was extracted in dichloromethane in order to study the formation of volatile compounds over time. The results showed the presence of a large number of short chain fatty acids, namely pentadecanoic acid (12.21 mg %), known to have antiarthritic property; nonadecanoic acid (13.99 mg %), which has anti-inflammatory action; benzoic acid, used as antiseptic (1.26 mg %), which showed a maximum yield after 16 h of incubation at 37 °C in MRS broth; nonacosane, having antibacterial activity (50.62 mg %); hexacosane, known for hair pigmentation (34.4 mg %); and nonacosanol, known to reduce cholesterol (8.62 mg %), which was found to be maximum after 7 days of incubation. All these compounds are known to be therapeutically important.

Anahtar Kelime: bacteria therapeutic agents GC-MS Leuconostoc paramesenteroides volatile compounds cheeses spectroscopy therapeutic diets flavour chromatography

Konular: Biyoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Gherty J. American dairy science association foundation, lecture. J Dairy Sci 78(7):1401, 1995.
2. Sanders ME. Overview of functional foods: emphasis on probiotic bacteria. Int Dairy J 8: 341-347,1998.
3.FAO/WHO.Report Guidelines for the evaluation of probiotics in food. London, Ontario, Canada, April 30 and May 1, 2002.
4. Naidu AS, Biblack WR, Clemens RA. Probiotic spectra of lactic acid bacteria. CRC Crit Rev Fd Sci Nutr 39: 13-126, 2000.
5. Marteau & Boutron. Nutritional advantages of probiotic and prebiotics. Br J Nutr 87: 153-157, 2002.
6. Savaiano DA, Abou Ei Anouas A, Smith DE et al. Lactose malabsorption from yogurt,pasteurized yogurt, sweet acidophilus milk and cultured milk in lactose- deficient individuals. Am J Clin Nutr 40: 1219-1223, 1984.
7. Haudault S, Lieven V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 63: 513-518, 1997.
8. Pool-Zobel BL, Bertram B, Knoll M et al. Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats. Nutr Cancer 20: 271 -281, 1993.
9. Mikes Z, Ferencik M, Jahnova E et al. Hypocholesterolemic and immunostimulatory effects of orally applied Enterococcus faecium M-74 in man. Folia Microbiol 40: 639-646, 1995.
10. Malin M, Suomalainen H, Saxelin M et al. Promotion of igA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Annals Nutr Metab 40: 137-145, 1996.
11. Tamai Y, Yoshimitsu N, Watanabe Y et al. Effects of milk fermented by culturing with various lactic acid bacteria and a yeast on serum cholesterol levels in rats. J Ferm Bioeng 81, 181- 182.
12. Steele JL, Unlu G. Impact of lactic acid bacteria on cheese flavor development. Fd Technol 46: 128-135, 1993.
13. Martley FC, Crow VL. Interaction between non-starter microorganism during cheese manufacture and ripening. Int Dairy J 3: 461-483, 1993.
14. Percival M. Choosing a probiotic supplement. Clin Nutr Insights 1997.
15. Topping LD. Short chain fatty acid produced by intestinal bacteria. Asia Pacific J Clin Nutr 5: 15-19, 1996.
16. Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther 12: 499-507, 1998.
17. Alonso L, Fraga MJ. Simple and rapid analysisfor quantitation of most important volatile flavor compounds in yogurt by headspace GC-MS. J Chromatographic Sci 39: 297-300, 2001.
18. Richelieu M, Houlberg U, Nielsen JC. Determination of oc~ acetolactic acid and volatile compounds by head space gas chromatograph. J Dairy Sci 80: 1918-1925, 1997.
19. Agrawal R, Rati ER, Vijayendra SVN et al. Flavour profile of idli batter prepared from defined micnobial starter cultures. World J Microbiol Biotechnol 16: 687-690, 2000.
20. Murti TW, Bouillanne C, Landon M et al. Bacterial growth and volatile compounds in yogurt type products from soymilk containing Bifidobacterium sp. J Food Sci 58: 153, 1993.
21. Gallard-Escamilla FJ, Kelly AL, Delahunty CM. Influence of starter culture of flavor and headspace volatile profiles of fermented whey and whey produced from fermented milk. J Dairy Sci 88: 3745-3753, 2005.
22. Ishibashi N, Shimamus S. Bifidobacteria: research and development in Japan. Food Technol 47: 126-135, 1993.
23. Krieg N. ed. Bergey's Manual of Systematic Bacteriology, Vol 2. Baltimore: Willia; 1984.
24. Nel HA, Corine JM, Dicks MT. Sluggish/Stuck malolactic fermentation in chardonnay: possible causes. Wynboer, A Technical Guide for Wine Producers. 2000.
25. Hirschler A, Rontani JF, Raphel D et al. Anaerobic degradation of hexadecane-2-one by a microbial enrichment culture under sulfate reducing conditions. Appl Environ Microbiol 64: 1576-1579, 1998.
26. Quiding H, Okrala E, Happonen RP et al. The visual analogue scale in multiple dose evaluations of analgesics. J Clin Pharmacol 21: 424,1981.
27. Canetti M, Moreira M, Mas R et al. A two year study on the efficacy and tolerability of policosanol in patients with type 11 hyperlipoproteinaemia. Int J Clin Pharmacol Res 15: 159-165, 1995.
28. Pons P, Rodriguez M, Robaina C et al. Effect of successive dose increase of policosanol on the lipid profile of patients with type 11 hyperlipoproteinaemia and tolerability to treatment. Int J Clin Pharmacol Res 14: 27-33, 1994.
29. Fernandez JC, Mas R, Cartano G et al. Comparison of efficacy, safety and tolerability of policosanol versus fluvartatin in elderly hypercholesteromic women. Clin Drug Invest 21: 103-113,2001.
30. Ortensi G, Gladstein J, Valli H et al. Comparative study of policosanol versus simuastst in elderly patients with hypercholesterolemia. Curr Ther Res 58: 390-401, 1997.
31. Shahani KM, Vakil JR, Kilara A. Natural antibiotic activity of Lactobacillus acidophilus and Lactobacillus bulgaricus. Cult Dairy Prod J 11: 14-17, 1976.
32. Masja N, Nierop Groot, Jan AM deBont. Conversion of phenylalanine to benzaldehyde initiated by an aminotransferase in lactobacillus plantarum. Appl Environ Microbiol 64: 3009-3013, 1998.
33. White SW, Zheng J, Zhang YM et al. The structural biology of type II fatty acid biosynthesis. Ann Rev Biochem 74: 791-831, 2005.
34. Kaneda T. Iso and anteiso- fatty acids in bacteria: biosynthesis, function and taxonomic significance. Microbiol Rev 55: 288-302, 1991.
35. So CM, Phelps CD, Young LY. Anaerobic transformation of alkanes to fatty acids by a sulphate reducing bacterium, Strain HXd3. Appl Environ Microbiol 69: 3892-3900, 2003'.
36. Thierry A, Maillard MB. Production of cheese flavor compounds derived from aminoacid catabolism by Propionibacterium freudenreichei. Lait82: 17-32, 2002.

APA	SHOBHA R, AGRAWAL R (2007). Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. , 35 - 40.
Chicago	SHOBHA Rani P.,AGRAWAL Renu Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. (2007): 35 - 40.
MLA	SHOBHA Rani P.,AGRAWAL Renu Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. , 2007, ss.35 - 40.
AMA	SHOBHA R,AGRAWAL R Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. . 2007; 35 - 40.
Vancouver	SHOBHA R,AGRAWAL R Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. . 2007; 35 - 40.
IEEE	SHOBHA R,AGRAWAL R "Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate." , ss.35 - 40, 2007.
ISNAD	SHOBHA, Rani P. - AGRAWAL, Renu. "Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate". (2007), 35-40.

APA	SHOBHA R, AGRAWAL R (2007). Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. Turkish Journal of Biology, 31(1), 35 - 40.
Chicago	SHOBHA Rani P.,AGRAWAL Renu Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. Turkish Journal of Biology 31, no.1 (2007): 35 - 40.
MLA	SHOBHA Rani P.,AGRAWAL Renu Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. Turkish Journal of Biology, vol.31, no.1, 2007, ss.35 - 40.
AMA	SHOBHA R,AGRAWAL R Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. Turkish Journal of Biology. 2007; 31(1): 35 - 40.
Vancouver	SHOBHA R,AGRAWAL R Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate. Turkish Journal of Biology. 2007; 31(1): 35 - 40.
IEEE	SHOBHA R,AGRAWAL R "Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate." Turkish Journal of Biology, 31, ss.35 - 40, 2007.
ISNAD	SHOBHA, Rani P. - AGRAWAL, Renu. "Volatile compounds of therapeutic importance produced by Leuconostoc paramesenteroides, a Native laboratory Isolate". Turkish Journal of Biology 31/1 (2007), 35-40.